# Norwood Financial Corp: financial statements, quarterly

NWFL · Nasdaq · CIK 1013272 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nwfl.md) · [Financials](/companies/nwfl/financials.md) · [Filings](/companies/nwfl/filings.md) · [Insiders](/companies/nwfl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nwfl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.9](/filings/0001562762-24-000265.md) | [1.8 d](/filings/0001562762-25-000042.md) | [1.7](/filings/0001562762-25-000120.md) | [1.9](/filings/0001562762-25-000204.md) | [1.9](/filings/0001013272-25-000004.md) | [1.9 d](/filings/0001013272-26-000003.md) | [2.0](/filings/0001013272-26-000005.md) | [1.9](/filings/0001013272-26-000016.md) | [2.0](/filings/0001013272-25-000004.md) | [2.1 d](/filings/0001013272-26-000003.md) | [2.3](/filings/0001013272-26-000005.md) | [2.1](/filings/0001013272-26-000016.md) |
| Interest expense | $m | [9.5](/filings/0001562762-23-000420.md) | [10.8 d](/filings/0001562762-24-000057.md) | [12.2](/filings/0001562762-24-000132.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.1](/filings/0001562762-24-000265.md) | [0.1 d](/filings/0001562762-25-000042.md) | [1.2](/filings/0001562762-25-000120.md) | [1.1](/filings/0001562762-25-000204.md) | [1.0](/filings/0001013272-25-000004.md) | [(3.4) d](/filings/0001013272-26-000003.md) | [1.5](/filings/0001013272-26-000005.md) | [1.6](/filings/0001013272-26-000016.md) | [2.2](/filings/0001013272-25-000004.md) | [1.9 d](/filings/0001013272-26-000003.md) | [1.1](/filings/0001013272-26-000005.md) | [2.3](/filings/0001013272-26-000016.md) |
| Net income | $m | [4.1](/filings/0001562762-24-000265.md) | [0.4 d](/filings/0001562762-25-000042.md) | [4.4](/filings/0001562762-25-000120.md) | [4.2](/filings/0001562762-25-000204.md) | [3.8](/filings/0001013272-25-000004.md) | [(12.7) d](/filings/0001013272-26-000003.md) | [5.8](/filings/0001013272-26-000005.md) | [6.2](/filings/0001013272-26-000016.md) | [8.3](/filings/0001013272-25-000004.md) | [7.4 d](/filings/0001013272-26-000003.md) | [3.7](/filings/0001013272-26-000005.md) | [9.3](/filings/0001013272-26-000016.md) |
| Diluted EPS | $ per share | [0.51](/filings/0001562762-24-000265.md) | not reported | [0.55](/filings/0001562762-25-000120.md) | [0.52](/filings/0001562762-25-000204.md) | [0.48](/filings/0001013272-25-000004.md) | not reported | [0.63](/filings/0001013272-26-000005.md) | [0.67](/filings/0001013272-26-000016.md) | [0.89](/filings/0001013272-25-000004.md) | not reported | [0.35](/filings/0001013272-26-000005.md) | [0.86](/filings/0001013272-26-000016.md) |
| Basic EPS | $ per share | [0.51](/filings/0001562762-24-000265.md) | not reported | [0.55](/filings/0001562762-25-000120.md) | [0.52](/filings/0001562762-25-000204.md) | [0.48](/filings/0001013272-25-000004.md) | not reported | [0.63](/filings/0001013272-26-000005.md) | [0.67](/filings/0001013272-26-000016.md) | [0.89](/filings/0001013272-25-000004.md) | not reported | [0.35](/filings/0001013272-26-000005.md) | [0.86](/filings/0001013272-26-000016.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,180](/filings/0001562762-23-000420.md) | [2,201](/filings/0001562762-25-000042.md) | [2,260](/filings/0001562762-24-000132.md) | [2,235](/filings/0001562762-24-000201.md) | [2,280](/filings/0001562762-24-000265.md) | [2,317](/filings/0001013272-26-000003.md) | [2,376](/filings/0001562762-25-000120.md) | [2,365](/filings/0001562762-25-000204.md) | [2,412](/filings/0001013272-25-000004.md) | [2,425](/filings/0001013272-26-000016.md) | [2,917](/filings/0001013272-26-000005.md) | [2,908](/filings/0001013272-26-000016.md) |
| Total liabilities | $m | [2,015](/filings/0001562762-23-000420.md) | [2,020](/filings/0001562762-25-000042.md) | [2,079](/filings/0001562762-24-000132.md) | [2,053](/filings/0001562762-24-000201.md) | [2,084](/filings/0001562762-24-000265.md) | [2,104](/filings/0001013272-26-000003.md) | [2,155](/filings/0001562762-25-000120.md) | [2,140](/filings/0001562762-25-000204.md) | [2,177](/filings/0001013272-25-000004.md) | [2,183](/filings/0001013272-26-000016.md) | [2,633](/filings/0001013272-26-000005.md) | [2,618](/filings/0001013272-26-000016.md) |
| Short-term borrowings | $m | [104](/filings/0001562762-23-000420.md) | [74.1](/filings/0001562762-25-000042.md) | [60.1](/filings/0001562762-24-000132.md) | [62.3](/filings/0001562762-24-000201.md) | [52.5](/filings/0001562762-24-000265.md) | [113](/filings/0001013272-26-000003.md) | not reported | [26.5](/filings/0001562762-25-000204.md) | not reported | [14.7](/filings/0001013272-26-000016.md) | not reported | not reported |
| Shareholders' equity | $m | [165](/filings/0001562762-24-000265.md) | [181](/filings/0001013272-26-000003.md) | [181](/filings/0001562762-25-000204.md) | [182](/filings/0001013272-25-000004.md) | [196](/filings/0001013272-25-000004.md) | [214](/filings/0001013272-26-000016.md) | [221](/filings/0001013272-26-000016.md) | [225](/filings/0001013272-26-000016.md) | [235](/filings/0001013272-25-000004.md) | [242](/filings/0001013272-26-000016.md) | [284](/filings/0001013272-26-000016.md) | [290](/filings/0001013272-26-000016.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [6,884 d](/filings/0001562762-24-000265.md) | [6,715 d](/filings/0001562762-25-000042.md) | [4,251](/filings/0001562762-25-000120.md) | [9,105 d](/filings/0001562762-25-000204.md) | [4,645 d](/filings/0001013272-25-000004.md) | [4,806 d](/filings/0001013272-26-000003.md) | [9,098](/filings/0001013272-26-000005.md) | [6,755 d](/filings/0001013272-26-000016.md) | [9,339 d](/filings/0001013272-25-000004.md) | [8,775 d](/filings/0001013272-26-000003.md) | [5,997](/filings/0001013272-26-000005.md) | [8,906 d](/filings/0001013272-26-000016.md) |
| Capital expenditure | $k | [228 d](/filings/0001562762-24-000265.md) | [916 d](/filings/0001562762-25-000042.md) | [554](/filings/0001562762-25-000120.md) | [533 d](/filings/0001562762-25-000204.md) | [573 d](/filings/0001013272-25-000004.md) | [1,467 d](/filings/0001013272-26-000003.md) | [932](/filings/0001013272-26-000005.md) | [1,677 d](/filings/0001013272-26-000016.md) | [1,037 d](/filings/0001013272-25-000004.md) | [1,074 d](/filings/0001013272-26-000003.md) | [455](/filings/0001013272-26-000005.md) | [498 d](/filings/0001013272-26-000016.md) |
| Dividends paid | $k | [2,340 d](/filings/0001562762-24-000265.md) | [2,340 d](/filings/0001562762-25-000042.md) | [2,433](/filings/0001562762-25-000120.md) | [2,433 d](/filings/0001562762-25-000204.md) | [2,426 d](/filings/0001013272-25-000004.md) | [2,427 d](/filings/0001013272-26-000003.md) | [2,875](/filings/0001013272-26-000005.md) | [2,871 d](/filings/0001013272-26-000016.md) | [2,872 d](/filings/0001013272-25-000004.md) | [2,871 d](/filings/0001013272-26-000003.md) | [3,506](/filings/0001013272-26-000005.md) | [3,485 d](/filings/0001013272-26-000016.md) |
| Share repurchases | $k | [0.0 d](/filings/0001562762-24-000265.md) | [23.0 d](/filings/0001562762-25-000042.md) | not reported | not reported | [96.0 d](/filings/0001013272-25-000004.md) | [27.0 d](/filings/0001013272-26-000003.md) | [349](/filings/0001013272-26-000005.md) | [0.0 d](/filings/0001013272-26-000016.md) | [0.0 d](/filings/0001013272-25-000004.md) | [12.0 d](/filings/0001013272-26-000003.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [8.1](/filings/0001562762-23-000420.md) | [8.1](/filings/0001562762-24-000132.md) | [8.1](/filings/0001562762-24-000201.md) | [8.0](/filings/0001562762-24-000265.md) | [8.1](/filings/0001562762-25-000120.md) | [8.0](/filings/0001562762-25-000204.md) | [8.1](/filings/0001013272-25-000004.md) | [9.2](/filings/0001013272-26-000005.md) | [9.2](/filings/0001013272-26-000016.md) | [9.3](/filings/0001013272-25-000004.md) | [10.8](/filings/0001013272-26-000005.md) | [10.8](/filings/0001013272-26-000016.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,902,074 at 2026-08-01, from the cover of the [10-Q filed 2026-08-07](/filings/0001013272-26-000016.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.